Specify a stock or a cryptocurrency in the search bar to get a summary
2Seventy Bio Inc
TSVT2seventy bio, Inc., a cell and gene therapy company, focuses on the research, development, and commercialization of treatments for cancer in the United States. The company's products pipeline includes Abecma, a chimeric antigen receptor T-cell product candidates for the treatment of multiple myeloma. It has a collaboration arrangement with Bristol Myers Squibb Company. The company was incorporated in 2021 and is headquartered in Cambridge, Massachusetts. Address: 60 Binney Street, Cambridge, MA, United States, 02142
Analytics
WallStreet Target Price
8.25 USDP/E ratio
–Dividend Yield
–Current Year
Last Year
Current Quarter
Last Quarter
Current Year
Last Year
Current Quarter
Last Quarter
Key Figures TSVT
Dividend Analytics TSVT
Dividend growth over 5 years
–Continuous growth
–Payout Ratio 5 years average
–Dividend History TSVT
Stock Valuation TSVT
Financials TSVT
Results | 2019 | Dynamics |